Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
3,150
119th Congress
Top supporter
Darline Graham
82% support rate
Top opponent
Rick Scott
19% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in United States

Legislators moving healthcare in United States
Legislator Party Stance Support rate Decisive votes
Darline Graham
Darline Graham Senate
R
Strong +
82% 11
Peter Welch
Peter Welch Senate
D
Strong +
81% 27
Ron Wyden
Ron Wyden Senate
D
Support
78% 27
Alex Padilla
Alex Padilla Senate
D
Support
77% 26
Mazie K. Hirono
Mazie K. Hirono Senate
D
Support
74% 27
Rick Scott
Rick Scott Senate
R
Strong −
19% 27
Ashley Moody
Ashley Moody Senate
R
Oppose
22% 27
Rand Paul
Rand Paul Senate
R
Oppose
22% 27
Brad Knott
Brad Knott House · District 13
R
Oppose
28% 18
Pat Harrigan
Pat Harrigan House · District 10
R
Oppose
28% 18
Showing 2,281–2,290 of 3,150 bills

All healthcare bills

in committee · United States · Senate May 1, 2025

S 1562: PREEMIE Reauthorization Act of 2025

This bill reauthorizes federal research funding for preterm birth prevention and infant care through 2029, extending the previous program period. It mandates a comprehensive study by the National Academies on the financial costs of preterm births (including NICU stays and long-term family expenses), factors influencing preterm birth rates, and opportunities for early detection. The study requires a final report with raw data to Congress within 24 months, covering research strategies, state best practices, and precision medicine approaches. The bill directly affects the Department of Health and Human Services (which must establish an interagency working group), the National Academies (as the study contractor), and Congress (as the recipient of the final report).
Sub-Topics Children's Health
in committee · United States · Senate May 12, 2025

S 1716: Vision Lab Choice Act of 2025

This bill, S 1716 (Vision Lab Choice Act of 2025), modifies vision care coverage under health plans by limiting agreements between optometrists and vision plans to two-year terms (with possible two-year extensions) and prohibiting plans from restricting optometrists' choices of labs or suppliers for patient vision care. It directly affects optometrists and health insurance issuers offering limited-scope vision benefits, ensuring they cannot force optometrists to use specific labs or materials. The bill requires annual state enforcement notifications by the Secretary and clarifies that state laws governing vision plans take precedence if they conflict with this law. It does not change overall coverage requirements but focuses on provider choice and contract terms within vision benefit plans.
Sub-Topics Insurance
in committee · United States · House Jun 12, 2025

HR 3947: Easy Enrollment in Health Care Act

The Easy Enrollment in Health Care Act (HR 3947) would streamline enrollment in health insurance programs by allowing taxpayers to use their federal tax return information to determine eligibility for coverage. Individuals filing tax returns would be able to consent to share relevant tax data (like income and family size) with health insurance exchanges, enabling automatic enrollment in zero-net-premium plans without additional paperwork. The bill establishes a "single, streamlined application" process that minimizes redundant information requests while maintaining privacy protections. It also modernizes eligibility criteria for Medicaid and CHIP programs by allowing states to use tax return data for income determinations, making it easier for eligible individuals to access coverage. This would directly affect millions of Americans who qualify for health insurance assistance through federal or state programs.
in committee · United States · Senate Mar 5, 2025

S 863: Genomic Data Protection Act

S 863, the Genomic Data Protection Act, gives consumers greater control over their genetic information collected by direct-to-consumer genetic testing companies (like 23andMe or AncestryDNA). It requires these companies to provide simple tools for consumers to access their genomic data, delete their accounts (including associated data), and request destruction of biological samples (such as saliva swabs). Companies must also clearly disclose how deidentified data may be used for research and notify consumers 30 days before a company acquisition, detailing how consumer rights will be honored under new ownership. The Federal Trade Commission will enforce these requirements as unfair or deceptive practices under existing law, with companies required to fulfill deletion requests within 30 days. This bill directly affects consumers who use genetic testing services and the companies that collect their genomic data, excluding healthcare providers using genetic data for medical diagnosis.
passed · United States · Senate Dec 17, 2025

S 355: FDA Modernization Act 3.0

FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.  The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate.  The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
in committee · United States · Senate Jan 27, 2026

S 3703: Rural Veterans’ Improved Access to Benefits Act of 2026

This bill expands access to VA disability examinations for rural veterans by allowing a broader range of health care professionals to conduct these exams under temporary contracts. It revises eligibility requirements to include any licensed health care professional (replacing specific titles like "physicians assistants" with a general category) who meets state licensing standards and is contracted by the VA. The bill extends the temporary authority for these contracts until September 30, 2031, and requires the VA to report on exam volume, costs, and accuracy within 15 months of enactment. These changes aim to improve timely benefit access in rural areas where specialized examiners may be scarce.
in committee · United States · House Jan 22, 2025

HR 632: Protecting Life on College Campus Act of 2025

HR 632 prohibits federal funding (directly or indirectly) for colleges and universities that host or are affiliated with campus health clinics providing abortion drugs or abortions to students or employees. Institutions must annually certify to federal education and health agencies that no such services are offered at their campus sites. The bill defines "abortion drugs" broadly as any medication intended to terminate pregnancy (excluding cases for live birth, miscarriage management, or ectopic pregnancy treatment). This policy directly affects institutions receiving federal funds, requiring them to ensure campus health services comply with the prohibition to maintain eligibility.
in committee · United States · Senate Feb 20, 2025

S 665: Fatal Overdose Reduction Act of 2025

The Fatal Overdose Reduction Act of 2025 establishes a Medicaid demonstration program to create "Health Engagement Hubs" that provide comprehensive, drop-in services for people with opioid use disorder and other substance use disorders. These hubs would offer harm reduction services, medication-assisted treatment, counseling, and social services like housing assistance and job training, with a focus on communities disproportionately impacted by overdose deaths. States would develop payment systems for these services, with up to 10 states selected to participate for 5 years, and would be required to report on outcomes like overdose rates and treatment access. The program would be funded through a $60 million planning grant and would require states to track demographic and health outcomes to assess effectiveness.
in committee · United States · House Mar 11, 2025

HR 2049: Access to Family Building Act

The Access to Family Building Act establishes legal rights for individuals seeking fertility care and health care providers offering assisted reproductive technology (ART) services. It prohibits states or localities from imposing unreasonable restrictions on ART access - such as excessive costs, health barriers, or arbitrary limitations - that don’t advance safety or health outcomes. The bill allows patients, providers, or insurers to sue to enforce these rights, while explicitly preserving state health/safety regulations that protect patient safety. It does not override existing state insurance laws or require changes to medical facility safety standards. This bill directly affects patients pursuing fertility treatment, fertility clinics, and health insurers covering ART services.
in committee · United States · House Jun 11, 2025

HR 3906: Medical Research for Our Troops Act

HR 3906, the Medical Research for Our Troops Act, restores funding levels for military medical research by increasing the Defense Health Agency's research budget from $40.395 billion to $41.576 billion in the 2025 appropriations act. It ensures Congressionally Directed Medical Research Programs funds are used consistently with the Consolidated Appropriations Act, 2024, requiring the Defense Secretary to support all previously identified research programs and maintain existing funding allocations. The bill directly affects military medical research initiatives and the Defense Health Agency's budget implementation. This is a procedural funding adjustment, not a new policy, maintaining continuity for ongoing research projects.
Sub-Topics Appropriations
Showing 2,281 to 2,290 of 3,150 bills